Does the FDA approved cefepime injection treat urinary tract infections in patients?
Cefepime is a cephalosporin antibiotic that is FDA-approved for several infections, including urinary tract infections (UTIs). The FDA label specifically lists cefepime for injection as a treatment for both uncomplicated and complicated UTIs caused by susceptible bacteria 8. This means that in appropriate cases, cefepime can be used to treat UTIs, but it should only be used when the bacteria are known or strongly suspected to be sensitive to it.
What the research says
The FDA-approved labeling for cefepime for injection and dextrose injection includes uncomplicated and complicated urinary tract infections as an approved indication 8. This approval is based on clinical trials demonstrating its effectiveness against susceptible strains of bacteria that cause UTIs. Additionally, a phase 3 trial (Integral-1) found that a combination of cefepime with nacubactam was non-inferior to imipenem-cilastatin for complicated UTIs and pyelonephritis 2. While this study tested a combination product, it supports cefepime's role in treating complicated UTIs. Other sources discuss UTI treatment and resistance patterns but do not directly address cefepime's approval for UTIs 134567.
What to ask your doctor
- Is cefepime a good option for my specific type of UTI, given my medical history?
- Have my urine culture results shown that the bacteria causing my infection are susceptible to cefepime?
- Are there any other antibiotics that might be more appropriate based on local resistance patterns?
- What are the potential side effects of cefepime, and how do they compare to other UTI treatments?
- Should I be concerned about antibiotic resistance when using cefepime for my UTI?
This question is drawn from common patient questions about Nephrology and answered using cited medical research. We do not provide individualized advice.